Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2014

View Archived Issues

ApoE2 gene delivery reduces amyloid burden in the brain of transgenic mice

Genetic diversity affects susceptibility to Ebola virus infection

IOmet Pharma describes novel small-molecule GLUT-1 inhibitors for cancer

BioCryst reports data for BCX-4430 in model of Ebola virus infection

Elios Therapeutics' personalized cancer vaccine cleared for phase IIb testing

Cancer Research UK, CRT and Amgen to study AMG-319 in solid tumors

Roivant Neurosciences acquires SB-742457 from GlaxoSmithKline

Amarantus BioScience's Alzheimer's disease diagnostic available for use in clinical trials

Phylogica and Genentech enter antibacterial discovery collaboration

ADDC and AstraZeneca to support five high-throughput screening proposals

Endo Pharmaceuticals and BioDelivery Sciences submit NDA for Buprenorphine Buccal Film

BioCryst receives orphan drug designation for BCX-4161 for hereditary angioedema

Amarantus receives FDA orphan drug designation for MANF for retinitis pigmentosa

FDA approves supplemental BLA for Gazyva

Takeda submits NDA in Japan for glatiramer acetate

Takecab approved for the treatment of acid-related diseases in Japan

Chugai Pharmaceutical obtains approval of vemurafenib in Japan

Cosentyx approved in Japan for psoriasis and psoriatic arthritis

Vimizim approved in Japan for Morquio A syndrome

European approval for Xpert HIV-1 Viral Load test

Chiesi Farmaceutici patents MAPK 14 inhibitors

CSIR divulges silicon-containing antituberculosis pyrroles

Merck KGaA reports discovery of MST1R inhibitor

FDA approves use of Kalydeco for R117H mutation in cystic fibrosis

Data presented on a new chimeric antigen receptor targeting cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...